SEARCH

SEARCH BY CITATION

References

  • 1
    Harada K, Hirohara J, Ueno Y et al. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan. Hepatology 2013; 57: 19421949.
  • 2
    Deutsch M, Papatheodoridis GV, Tzakou A, Hadziyannis SJ. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2008; 20: 59.
  • 3
    Liang Y, Yang Z, Zhong R. Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis. Hepatology 2012; 56: 14091417.
  • 4
    Floreani A, Biagini MR, Chiaramonte M, Milani S, Surrenti C, Naccarato R. Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). Ital J Gastroenterol 1993; 25: 473476.
  • 5
    Caballeria L, Pares A, Castells A, Ginés A, Bru C, Rodés J. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. Am J Gastroenterol 2001; 96: 11601163.
  • 6
    Shibuya A, Tanaka K, Miyakawa H et al. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. Hepatology 2002; 35: 11721178.
  • 7
    Jones DE, Metcalf JV, Collier JD, Bassendine MF, James OF. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology 1997; 26: 11381142.
  • 8
    Miyake Y, Iwasaki Y, Terada R et al. Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis. Aliment Pharmacol Ther 2006; 24: 11971205.
  • 9
    Nakano T, Inoue K, Hirohara J et al. Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a-PBC). Hepatol Res 2002; 22: 250260.
  • 10
    Turissini SB, Kaplan MM. Hepatocellular carcinoma in primary biliary cirrhosis. Am J Gastroenterol 1997; 92: 676678.
  • 11
    Kadokawa Y, Omagari K, Ohba K et al. Hepatocellular carcinoma in a male patient with early stage (stage I) primary biliary cirrhosis. Intern Med 2005; 44: 207211.
  • 12
    Silveira MG, Suzuki A, Lindor KD. Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis. Hepatology 2008; 48: 11491156.
  • 13
    Watanabe T, Soga K, Hirono H et al. Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis. World J Gastroenterol 2009; 15: 231239.
  • 14
    Sasaki H, Inoue K, Higuchi K et al. Primary biliary cirrhosis in Japan: national survey by the Subcommittee on Autoimmune hepatitis. Gastroenterol Jpn 1985; 20: 476485.
  • 15
    Hirohara J, Nakano T, Seki T et al. National surveys of primary biliary cirrhosis – Results from the 15th survey of PBC patients in Japan – Research report of the Intractable Hepato-Biliary Diseases Study Group for Research on Measures for Intractable Disease (Health Labour Sciences Research Grants in Japan). (In Japanese.) 2013.
  • 16
    Findor J, He XS, Sord J, Terg R, Gershwin ME. Primary biliary cirrhosis and hepatocellular carcinoma. Autoimmun Rev 2002; 1: 220225.
  • 17
    Cavazza A, Caballeria L, Floreani A et al. Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers. Hepatology 2009; 50: 11621168.
  • 18
    Suzuki A, Lymp J, Donlinger J, Mendes F, Angulo P, Lindor K. Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007; 5: 259264.
  • 19
    Hirohara J, Nakano T, Seki T, Okazaki K, Nakanuma Y, Tsubouchi H. National surveys of primary biliary cirrhosis (PBC) in Japan. Nihon Shokakibyo Gakkai Zasshi 2013; 110: 815.
  • 20
    Komori A, Nakamura M, Abiru S et al. Hepatocellular carcinoma in patients with primary biliary cirrhosis; a multicenter study in National Hospital Organization Study Group of Liver Disease in Japan. The 47th Annual Meeting of Liver Cancer Study Group of Japan (Abstract). (In Japanese.) 2011:104.
  • 21
    Hosonuma K, Sato K, Yanagisawa M et al. Incidence, mortality, and predictive factors of hepatocellular carcinoma in primary biliary cirrhosis. Gastroenterol Res Pract 2013; 2013: 168012.
  • 22
    Hirohara J, Nakano M, Nakanuma Y et al. Clinical predictor for development of hepatocellular carcinoma in patients with primary biliary cirrhosis using nationwide survey in Japan. The 47th Annual Meeting of Liver Cancer Study Group of Japan (Abstract) (in Japanese) 2011:104.
  • 23
    Nakanuma Y, Terada T, Doishita K et al. Hepatocellular carcinoma in primary biliary cirrhosis: an autopsy study. Hepatology 1990; 11: 10101016.
  • 24
    Tanaka A, Takamori Y, Toda G et al. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis. Liver Int 2008; 28: 983989.
  • 25
    Mendes F, Lindor KD. Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol 2010; 7: 611619.
  • 26
    Nakanuma Y, Zen Y, Harada K et al. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement. Pathol Int 2010; 60: 167174.
  • 27
    Nakanuma Y, Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 1979; 76: 13261332.
  • 28
    Nijhawan PK, Therneau TM, Dickson ER et al. Incidence of cancer in primary biliary cirrhosis: the Mayo experience. Hepatology 1999; 29: 13961398.
  • 29
    Michitaka K, Nishiguchi S, Aoyagi Y et al. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol 2010; 45: 8694.
  • 30
    Kuiper EM, Hansen BE, Adang RP et al. Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid. Eur J Gastroenterol Hepatol 2010; 22: 14951502.
  • 31
    Naugler WE, Sakurai T, Kim S et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317 (5834): 121124.
  • 32
    Yeh SH, Chen PJ. Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology 2010; 78 (Suppl 1): 172179.